Trial intelligence / Profile preview

Microneedling With Lactic Acid, Vitamin D3, or Triamcinolone Acetonide in Alopecia Areata

NCT06327581Recruiting

Sponsor
Zagazig University
Start
Dec 2023
Primary completion
Dec 2026
Modality
Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
Countries
1
01

Overview

Randomised trial of lactic acid topical cream, cholecalciferol cream and triamcinolone acetonide in alopecia areata (4 arms), sponsored by Zagazig University. Primary endpoints: Severity of Alopecia Tool at 3 months and Percentage of hair growth at 3 months. Started Dec 2023; status: recruiting.

02

Drugs

lactic acid topical creamcholecalciferol creamtriamcinolone acetonide
03

Conditions

alopecia areata

Beyond the preview

Go deeper on NCT06327581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06327581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call